Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy.

被引：0

作者：

Renzulli, Matteo ^{[1
]}

Buonfiglioli, Federica ^{[2
]}

Brocchi, Stefano ^{[1
]}

Conti, Fabio ^{[2
]}

Serio, Ilaria ^{[4
]}

Caraceni, Paolo ^{[2
]}

Foschi, Francesco G. ^{[3
]}

Mazzella, Giuseppe ^{[2
]}

Verucchi, Gabriella ^{[2
]}

Andreone, Pietro ^{[2
]}

Golfieri, Rita ^{[1
]}

Brillanti, Stefano ^{[2
]}

机构：

[1] St Orsola Marcello Malpighi Hosp, Dept Diagnost Med & Prevent, Bologna, Italy

[2] Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy

[3] St Orsola Marcello Malpighi Hosp, Bologna, Italy

[4] Osped Faenza, Faenza, Italy

来源：

HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

440

引用

页码：223A / 224A

页数：2

共 50 条

[1] Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
Matteo Renzulli
Federica Buonfiglioli
Fabio Conti
Stefano Brocchi
Ilaria Serio
Francesco Giuseppe Foschi
Paolo Caraceni
Giuseppe Mazzella
Gabriella Verucchi
Rita Golfieri
Pietro Andreone
Stefano Brillanti
European Radiology, 2018, 28 : 506 - 513
[2] Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
Renzulli, Matteo
Buonfiglioli, Federica
Conti, Fabio
Brocchi, Stefano
Serio, Ilaria
Foschi, Francesco Giuseppe
Caraceni, Paolo
Mazzella, Giuseppe
Verucchi, Gabriella
Golfieri, Rita
Andreone, Pietro
Brillanti, Stefano
EUROPEAN RADIOLOGY, 2018, 28 (02) : 506 - 513
[3] RISK OF HEPATOCELLULAR CARCINOMA IN HCV-RELATED CIRRHOSIS TREATED WITH DIRECT-ACTING ANTIVIRAL (DAA) THERAPY
Kilany, Shimaa
Gomaa, Asmaa Ibrahim
Sabry, Alyaa
Moaz, Inas
Ezzat, Sameera
Badra, Gamal Ahmed
Waked, Imam
HEPATOLOGY, 2019, 70 : 321A - 322A
[4] Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Conti, Fabio
Buonfiglioli, Federica
Scuteri, Alessandra
Crespi, Cristina
Bolondi, Luigi
Caraceni, Paolo
Foschi, Francesco Giuseppe
Lenzi, Marco
Mazzella, Giuseppe
Verucchi, Gabriella
Andreone, Pietro
Brillanti, Stefano
JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 727 - 733
[5] Letter: direct-acting agent therapy and HCV-related Child C cirrhosis
Braillon, A.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (04) : 476 - 476
[6] Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis
Virseda-Berdices, Ana
Brochado-Kith, Oscar
Diez, Cristina
Hontanon, Victor
Berenguer, Juan
Gonzalez-Garcia, Juan
Rojo, David
Fernandez-Rodriguez, Amanda
Ibanez-Samaniego, Luis
Llop-Herrera, Elba
Olveira, Antonio
Perez-Latorre, Leire
Barbas, Coral
Rava, Marta
Resino, Salvador
Jimenez-Sousa, Maria Angeles
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (03) : 719 - 726
[7] Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
Hanafy, Amr Shaaban
Bassiony, Mohamed A.
Basha, Mohammad Abd Alkhalik
HEPATOLOGY INTERNATIONAL, 2019, 13 (02) : 165 - 172
[8] Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
Amr Shaaban Hanafy
Mohamed A. Bassiony
Mohammad Abd Alkhalik Basha
Hepatology International, 2019, 13 : 165 - 172
[9] Risk factors of development of hepatocellular carcinoma in HCV patients after direct-acting antiviral therapy
Morimoto, Naoki
Isoda, Norio
Miura, Kouichi
Watanabe, Shunji
Takaoka, Yoshinari
Tsukui, Mamiko
Murayama, Kozue
Hirosawa, Takuya
Yamamoto, Hironori
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 156 - 156
[10] Hepatocellular carcinoma after direct-acting antiviral therapy for chronic HCV infection: Is it a real risk?
Dias, Catia
Duarte-Ribeiro, Filipa
Pipa, Sara
Barbosa, Ana Rita
Mota, Margarida
Vieira, Fernando Rosas
IDCASES, 2018, 14

← 1 2 3 4 5 →